Algernon Pharmaceuticals Inc. (CSE: AGN | FRANKFURT: AGW | OTCQB: AGNPF) is a clinical-stage pharmaceutical development company. Our unique drug repurposing strategy enables us to discover new therapeutic uses for existing drugs. This business model lowers investment, risk, and research periods while increasing active patent life.
Twitter: @AlgernonPharma
Facebook: @AlgernonPharmaceuticals
Company Details
- Employees
- 5
- Address
- 700 W Pender St, Suite 915,canada
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- algernonpharmaceuticals.com
- HQ
- Vancouver, British Columbia
Algernon Pharmaceuticals Inc. Questions
Algernon Pharmaceuticals Inc.'s website is algernonpharmaceuticals.com
Algernon Pharmaceuticals Inc.'s LinkedIn profile is https://ca.linkedin.com/company/algernon-pharmaceuticals
Algernon Pharmaceuticals Inc. has
5 employees.
View email and phone details for 5
employees at Algernon Pharmaceuticals Inc..
Algernon Pharmaceuticals Inc.'s industry is
Pharmaceutical Manufacturing
Algernon Pharmaceuticals Inc.'s top competitors are
Glustitch Inc.,
Akseera Pharma Corp,
Marvel Biosciences Corp.,
Enveric Biosciences, Inc.,
Andira Pharmaceuticals,
Tryp Therapeutics,
Biocidium Biopharmaceuticals,
Achieve Life Sciences,
Solvonis Therapeutics (Formerly Awakn),
Eupraxia Pharmaceuticals Inc..
Algernon Pharmaceuticals Inc.'s categories are Pharmaceutical Manufacturing
